在帕金森病中,渐进性诺亚上腺体退化和运动皮质功能障碍在帕金森病中
Wei Zhou1, Hong-Yuan Chu2,3
1Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington D.C., WA, 20007, USA.
Acta pharmacologica Sinica
|November 26, 2024
概括
帕金森氏症涉及到局部coeruleus norepinephrine (LC-NE) 神经元的损失,影响运动皮质功能并引起运动和非运动症状. 了解这种神经退行是帕金森病治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
背景情况:
- 脑部部位 (locus coeruleus norepinephrine) (LC-NE) 系统对于大脑的功能至关重要.
- 在LC-NE系统中的神经元损失是帕金森病 (PD) 的标志.
- LC-NE神经退化与PD中的非运动性症状有关,例如认知和睡眠障碍.
研究的目的:
- 探索LC-NE神经退行在帕金森病中运动皮质功能障碍中的作用.
- 了解运动皮质中诺拉上腺素枯竭如何导致PD病理生理学.
- 审查临床和临床前证据,将LC-NE退化与PD中的运动和非运动缺陷联系起来.
主要方法:
- 临床和临床前研究的综述.
- 讨论关于LC-NE系统和帕金森病的现有研究.
- 对noradrenergic退化对运动皮质功能影响的分析.
主要成果:
- LC-NE神经退行显著影响运动皮质功能.
- 运动皮层的功能障碍导致帕金森病的运动和非运动症状.
- 大脑皮层中诺拉德仁基和多巴胺基信号之间的相互作用与PD进展有关.
结论:
- LC-NE神经退化是帕金森病运动和非运动症状的关键因素.
- 需要进一步研究整合noradrenergic退化,以了解PD的皮质病理生理学.
- 针对LC-NE系统可能为帕金森病提供新的治疗策略.
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K


